NCT03375450View on ClinicalTrials.gov

Treatment and Exacerbation in COPD Subjects

CompletedOBSERVATIONAL
Enrollment

60,243

Participants

Timeline

Start Date

June 9, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Comparative Effectiveness Study
Interventions
OTHER

Standard of Care

Participants will be followed as per local routine primary healthcare practice

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY